| n | Sex (f/m) | Age (years) | Duration (days)* | Plasma Nfl (pg/mL) | Plasma t-Tau (pg/mL) | ||
---|---|---|---|---|---|---|---|---|
Mean + SD | 95% CI | Mean + SD | 95% CI | |||||
Controls | ||||||||
 HC | 70 | 22/48 | 64.7 ± 5.1 | – | 9.2 ± 3.4 | 8.4–10.0 | 2.5 ± 1.2 | 2.3–2.8 |
 NND | 26 | 13/13 | 64.1 ± 6.9 | – | 23.4 ± 39.6 | 7.4–39.5 | 3.7 ± 2.4 | 2.7–4.7 |
 NND-Dem | 17 | 9/8 | 63.2 ± 16.9 | – | 182.2 ± 151.5 | 104.3–260.1 | 3.1 ± 2.4 | 1.8–4.3 |
Neurodegenerative and vascular dementia | ||||||||
 AD | 44 | 26/18 | 68.5 ± 10.9 | – | 34.9 ± 33.4 | 24.7–45.8 | 3.6 ± 2.4 | 2.8–4.3 |
 CJD | 83 | 53/30 | 66.6 ± 8.8 | 273.4 ± 276.9 | 349.7 ± 505.4 | 239.4–460.1 | 45.1 ± 48.7 | 34.5–55.7 |
 MM | 51 | 36/16 | 66.8 ± 9.6 | 236.9 ± 213.7 | 384.5 ± 492.7 | 246.0–523.1 | 59.8 ± 54.4 | 44.6–75.1 |
 MV | 11 | 4/7 | 65.6 ± 7.1 | 316.3 ± 20.1 | 174.9 ± 118.4 | 95.3–254.4 | 23.7 ± 24.9 | 6.9–40.4 |
 VV | 18 | 11/7 | 68.9 ± 6.7 | 369.5 ± 417.3 | 395.1 ± 689.4 | 52.3–737.9 | 16.5 ± 19.3 | 6.9–26.2 |
 DLB/PDD | 35 | 11/24 | 69.8 ± 8.3 | – | 46.8 ± 37.1 | 33.8–59.7 | 2.3 ± 1.4 | 1.8–2.7 |
 FTD | 12 | 8/4 | 69.5 ± 7.2 | – | 27.8 ± 29.6 | 7.9–47.8 | 2.3 ± 1.3 | 1.4–3.1 |
 VAD | 22 | 15/5 | 70.0 ± 9.9 | – | 56.35 ± 51.7 | 33.4–79.3 | 3.2 ± 2.8 | 2.0–4.8 |